PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures, such as positron emission tomography (PET) scan and
computated tomography (CT) scan, may help doctors predict a patient's response to treatment
and may help plan the best treatment. Drugs used in chemotherapy, such as doxorubicin and
ifosfamide, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving chemotherapy before surgery may make the
tumor smaller and reduce the amount of normal tissue that needs to be removed.
PURPOSE: This clinical trial is studying how well PET scan combined with CT scan predicts
response in patients undergoing chemotherapy and surgery for soft tissue sarcoma.